← Browse by Condition
Medical Condition
oligodendroglioma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT06161974 Phase 2
Recruiting
Study of Olutasidenib and Temozolomide in HGG
Enrollment
60 pts
Location
United States, Austr...
Sponsor
Rigel Pharmaceuticals
NCT06989086
Recruiting
FearLess in NeuroOncology
Enrollment
112 pts
Location
United States
Sponsor
Virginia Commonwealth Universi...
NCT06930846
Recruiting
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Enrollment
125 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce...